Anikó Pálfi

Anikó Pálfi

Company: Heidelberg Pharma Research GmbH

Job title: Director, Biochemistry & Cell Biology

Seminars:

Panel Discussion – Examining to What Extent Target Expression is a Good Biomarker for Clinical Success 2:00 pm

How are targets best used as biomarkers? What are the biomarkers we could have to better understand the target? Does expected target expression translate into clinical efficacy? What screening approaches exist to improve patient selection and ultimately clinical outcomes?Read more

day: Day One

Targeted Cancer Therapy for Patients With 17p Deletion 1:30 pm

Discussing Del(17p) as a potential platform-wide predictive biomarker for amanitin based ADCs Highlighting superior efficacy of amanitin based ADCs in cancer models with 17p loss Outlining the expedited clinical development of HDP-101 for Del(17p) patientsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.